Cargando...

Alzheimer's disease drug development pipeline: 2019

INTRODUCTION: Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs. Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices. METHODS:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (N Y)
Autores principales: Cummings, Jeffrey, Lee, Garam, Ritter, Aaron, Sabbagh, Marwan, Zhong, Kate
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617248/
https://ncbi.nlm.nih.gov/pubmed/31334330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.05.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!